Healthcare

Major investment firms are building significant positions in Danaher Corporation, signaling confidence in the life sciences and diagnostics specialist despite...

As March 2026 unfolds, Innoviva continues to solidify its standing within the specialized healthcare market. Investor attention is pivoting toward...

Sangamo Therapeutics is advancing decisively with its investigational gene therapy, ST-920, for Fabry disease. The company has submitted critical data...

Anixa Biosciences continues to advance its oncology pipeline, supported by encouraging clinical data and a shareholder-endorsed management team. Recent developments...

Following a robust performance in fiscal 2025, Legend Biotech Corp is on the cusp of reaching profitability. Company leadership projects...

A significant clinical milestone has been reached in the treatment of generalized anxiety disorder (GAD), a condition affecting over 20...

A significant period of technical support for Ypsomed shares is set to end next Tuesday. The Swiss medical technology specialist...

Biotechnology firm Onco-Innovations has fortified its financial position by completing a private placement, securing crucial capital for its preclinical cancer...

Pharmaceutical giant Eli Lilly issued a significant public safety alert on March 12, 2026, concerning chemically contaminated compounded versions of...

In a strategic pivot that reshapes its market position, telehealth provider Hims & Hers Health has entered a major collaboration...